Authors
Latest:
The Agile Future of Medical Information: Meeting 21st-Century Demands for HealthcareCOVID-19 pandemic has accelerated raised expectations for medical information professionals.
Latest:
Operating Models for Successful DOL EngagementHow life sciences companies can design an effective operating model for DOL engagements.
Latest:
Viable Options: Packaging and Partnering for Successful Storage and Transport of Conventional Cold-Chain Vaccines for Covid-19***Live: Thursday, February 25, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET*** As strategic planning among manufacturers and logistics partners commences, this webinar will serve as a platform to discuss service offerings and explore the most effective possible solutions. *** On demand until Feb. 25, 2022***
Latest:
HEOR: From Proving Product Value to Proving Its Own WorthThe recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Latest:
Supporting Successful Pharma Leadership with Neuroscience-Based LearningTo effectively lead in today’s unpredictable environment, several major pharma companies are turning to a neuroscience-based learning approach to leadership development.
Latest:
No Half Measures: How Medical Affairs Can Maximize and Measure ValueEducation and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Latest:
How to Enhance DEI in Clinical TrialsIntegrating DEI strategies into clinical trials is both crucial for advancing biomedical knowledge and for bolstering trust and equitability within underrepresented communities.
Latest:
Inclusion Check-In: Who are You Giving Your Energy To?Three simple ways to build trust—by reaching outside your comfort zone.
Latest:
Developing Data Literacy with Training SimulationsIn order to address data literacy gaps amongst reps and managers, sales trainers are increasingly turning to computer-based business simulation games, writes Jeremy Lovelace.
Latest:
Creating Influence and Authority in Value-Based HealthcareWe may be only at the beginning of outcome-measured, value-based healthcare, but this is a chance for pharma organizations to show their mettle as roles are redefined and definitions of ‘value’ are agreed, says Gérard Klop of Vintura.
Latest:
Getting ‘Personal’ With Vaccine DevelopmentInnovative and continuous remote patient monitoring, along with AI-based predictive analytics, are advancing progress toward replacing the one-size-fits-all, population-driven vaccination model.
Latest:
Investing for Success: Finding the Right Launch BalanceChallenge assumptions and reset expectations when it comes to pre-launch SG&A investment to increase the odds of commercial success.
Latest:
From Uncertainty to Opportunity: Navigating IPAY 2028How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care
Latest:
Bringing Data to Life: How Tech-Savvy Life Sciences Companies Can Better Serve the Healthcare SectorGoing beyond traditional market segmentation to understand the technological and data analytics capacity of target customers.
Latest:
The JAKs Journey Offers Valuable Lessons for InnovatorsOpportunity remains despite regulatory and access obstacles.
Latest:
No Half Measures: How Medical Affairs Can Maximize and Measure ValueEducation and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Latest:
Your Trusted Resource for Mission Critical SolutionsThere’s a reason your facility’s most sensitive operations are called “mission critical.” Learn how ABM’s highly technical management services can take the worry out of maintaining your most specialized systems.
Latest:
Introducing Agentic AI: Its Revolutionary Potential in PharmaA look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.
Latest:
Don’t Fall for the Call of Placebo-Controlled Vaccine TrialsThe idea of denying people proven medicines in the name of research has a dark legacy in this country.
Latest:
Beyond the Data: Is Blockchain the Answer to Improving Global Health?The COVID-19 pandemic has shifted the adoption of digital platforms in pharma and has made the industry reconsider which technologies can improve global health moving forward.
Latest:
Q&A With Kevin O'Neill, president and CEO of GE HealthCare, Pharmaceutical DiagnosticsO'Neill discusses the company's place in the global market and recent advancements to improve the patient experience.
Latest:
The Manufacturing Edge on Path to MarketFDA backs the benefits of adopting continuous manufacturing, a strategy which has accelerated approval and launch timelines, and its Emerging Technology Program could be a helpful tool.
Latest:
Top cybersecurity threats, challenges pharma companies need to addressLearn about the evolving cyber-threat landscape affecting the pharmaceutical industry and the recommended approach to addressing those threats.
